Capillary thrombosis in the skin: A pathologic hallmark of severe/chronic rejection of human vascularized composite tissue allografts?

Transplantation

Volumn 100, Issue 4, 2016, Pages 954-957

  Kanitakis, Jean ^a   Petruzzo, Palmina ^a   Gazarian, Aram ^b   Karayannopoulou, Georgia ^c   Buron, Fannie ^a   Dubois, Valérie ^d   Thaunat, Olivier ^a   Badet, Lionel ^a   Morelon, Emmanuel ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b Clinique du Parc   (France)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; COMPLEMENT COMPONENT C4D; MYCOPHENOLATE MOFETIL; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY SPECIFICITY; CASE REPORT; CHRONIC GRAFT REJECTION; COMPOSITE GRAFT; CONFERENCE PAPER; DERMIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; DRUG DOSE INCREASE; FACIAL TRANSPLANTATION; FEMALE; FOLLOW UP; HAND AMPUTATION; HAND TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LICHENOID; LYMPHOCYTIC INFILTRATION; MACULOPAPULAR RASH; MALE; MICROTHROMBUS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CAPILLARY; SKIN DEFECT; T LYMPHOCYTE; TISSUE FIXATION; VASCULARIZED COMPOSITE ALLOTRANSPLANTATION; YOUNG ADULT; ADVERSE EFFECTS; AMPUTATION; BIOPSY; CAPILLARY; CHRONIC DISEASE; GRAFT REJECTION; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PROCEDURES; REOPERATION; SEVERITY OF ILLNESS INDEX; SKIN; THROMBOSIS; TIME FACTOR; TREATMENT OUTCOME; VASCULARIZATION;

ADULT; AMPUTATION; BIOPSY; CAPILLARIES; CHRONIC DISEASE; COMPOSITE TISSUE ALLOGRAFTS; FACIAL TRANSPLANTATION; FEMALE; GRAFT REJECTION; HAND TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; REOPERATION; SEVERITY OF ILLNESS INDEX; SKIN; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84961944335     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000882     Document Type: Conference Paper

References (19)

1. Dubernard JM, Owen E, Lefrançois N, et al. First human hand transplantation. Case report. Transpl Int. 2000;13(suppl. 1):S521-524.
2. IRHCTT. International Registry on Hand and Composite Tissue Transplantation. Available at: https://www.handregistry.com/. Updated 2016. Accessed February 02, 2015.
3. Kanitakis J. Skin rejection in human hand allografts: histological findings and grading system. In: Lanzetta M, Dubernard JM. (eds). Hand Transplantation. Springer-Verlag; 2007;249-258.
4. Kanitakis J, Jullien D, Petruzzo P, et al. Clinicopathologic features of graft rejection in the first human hand allograft. Transplantation. 2003;76: 688-693.
5. Cendales L, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant. 2008;8:1396-1400.
6. Diefenbeck M, Nerlich A, Schneeberger S, et al. Allograft vasculopathy after allogeneic vascularized knee transplantation. Transpl Int. 2011;24: e1-e5.
7. Kaufman CL, Ouseph R, Blair B, et al. Graft vasculopathy in clinical hand transplantation. Am J Transplant. 2012;12:1004-1016.
8. Kanitakis J, Karayannopoulou G, Lanzetta M, et al. Graft vasculopathy in the skin of a human hand allograft: implications for diagnosis of rejection of vascularized composite allografts. Transpl Int. 2014;27:e118-e123.
9. Petruzzo P, Kanitakis J, Testelin S, et al. Clinicopathological findings of chronic rejection in a face grafted patient. Transplantation. 2015.
10. Petruzzo P, Gazarian A, Kanitakis J, et al. Outcomes after bilateral hand allotransplantation: a risk/benefit ratio analysis. Ann Surg. 2015;261: 213-220.
11. Nadasdy T. Thrombotic microangiopathy in renal allografts: the diagnostic challenge. Curr Opin Organ Transplant. 2014;19:283-292.
12. Abrahimi P, Liu R, Pober JS. Blood vessels in allotransplantation. Am J Transplant. 2015;15:1748-1754.
13. Mengel M, Husain S, Hidalgo L, et al. Phenotypes of antibody-mediated rejection in organ transplants. Transpl Int. 2012;25:611-622.
14. Troxell M, Norman D, Mittalhenkle A. Glomerular fibrin thrombi in ABO and crossmatch compatible renal allograft biopsies. Pathol Res Pract. 2011; 207:15-23.
15. Barth RN, Rodriguez ED, Mundinger GS, et al. Vascularized bone marrow-based immunosuppression inhibits rejection of vascularized composite allografts in nonhuman primates. Am J Transplant. 2011;11: 1407-1416.
16. Morelon E, Kanitakis J, Petruzzo P. Immunological issues in clinical composite tissue allotransplantation: where do we stand today? Transplantation. 2012;93:855-859.
17. Weissenbacher A, Hautz T, Zelger B, et al. Antibody-mediated rejection in hand transplantation. Transpl Int. 2014;27:e13-e17.
18. Chandraker A, Arscott R, Murphy GF, et al. The management of antibody-mediated rejection in the first presensitized recipient of a full-face allotrans-plant. Am J Transplant. 2014;14:1446-1452.
19. Haas M, Sis B, Racusen LC, et al. Banff meeting report writing committee. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant. 2014; 14:272-283.